Cefixime 100 mg + Lactobacillus Spores 2.5 BS Dispersible Tablet

Cefixime 100 mg + Lactobacillus Spores 2.5 BS Dispersible Tablet is a dispersible tablet formulated with Cefixime 100 mg + Lactobacillus spores 2.5 BS. The active ingredient profile is Cefixime; Lactobacillus spores, placing the product in the cephalosporin antibiotic + probiotic combination category. Cefixime provides antibacterial activity, while the Lactobacillus component is included as a probiotic adjunct intended to support gastrointestinal microbial balance during antibiotic therapy. The dispersible dosage form is designed to disintegrate in water or disperse readily, subject to the manufacturer’s approved administration instructions. For website cataloguing, the composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. This product is intended for professional pharmaceutical presentation and should not be described using unapproved efficacy, cure or superiority claims. Clinical selection should depend on the patient, diagnosis, susceptibility or symptom profile, and the prescriber’s judgement. Prescription status, contraindications, precautions, interactions, adverse-effect information and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.